BridgeMD
New treatment option for Colonic Cancer
Official title Butyrophilins Role in Colon Cancer
ClinicalTrials.gov ID: NCT04185272
What this study is testing
What is analysis of BTN and BTNL status?
analysis of BTN and BTNL status is an investigational medicine, being studied as a potential treatment for colonic cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient is older than 18 years old,
- Signed participation consent,
- Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery...
- Performance Status (PS) 0 or 1
- affiliated to the social security or beneficiary
You likely can't join if
- Rectal cancer, colon cancer recurrence
- Emergency of colon cancer Surgery
- History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
- Patient who received neoadjuvant therapy other than chemotherapy
- Patient treated with immune-suppressors or long-course corticosteroids \<12 months
- Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
See the full eligibility criteria
- Patient is older than 18 years old,
- Signed participation consent,
- Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation...
- Performance Status (PS) 0 or 1
- affiliated to the social security or beneficiary
- Rectal cancer, colon cancer recurrence
- Emergency of colon cancer Surgery
- History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
- Patient who received neoadjuvant therapy other than chemotherapy
- Patient treated with immune-suppressors or long-course corticosteroids \<12 months
- Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
- Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
- Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.